📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Amicrobe

1.1 - Company Overview

Amicrobe Logo

Amicrobe

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of advanced biomaterials to prevent and treat infections, offering Amicidin-α Surgical gel for clean and clean-contaminated surgical procedures; Amicidin-β Solution for contaminated and infected tissues with tissue cleansing and microbicidal activity; Amicidin-α PFC for military prolonged field settings (up to 72 hours); and Amicidin-β/EF for emergency settings, including trauma and emergency cesarean delivery.

Products and services

  • Amicidin-β Solution: A medical-grade solution produced for direct application to contaminated and infected tissues in contaminated and dirty procedures, combining tissue cleansing with microbicidal activity at the source
  • Amicidin-α Surgical: A clinical-grade gel engineered for direct application to exposed tissues during clean and clean-contaminated procedures, preventing contamination and infection at the wound interface
  • Amicidin-β/EF: An emergency-grade formulation architected for trauma and emergency cesarean delivery in low- and middle-income settings, maintaining surfactant properties and microbicidal action during urgent tissue management

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Amicrobe

DDL Logo

DDL

HQ: The Netherlands Website
  • Description: Provider of diagnostic solutions in molecular virology, bioinformatics, molecular bacteriology, and pathology, supporting clinical trials globally across five continents. Offers infectious disease and vaccine development expertise, oncology trial support, rare disease cell and gene therapy operations, biologics and biosimilars services from preclinical to post-market, and customized kit building for sample integrity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DDL company profile →
SOM Biotech Logo

SOM Biotech

HQ: Spain Website
  • Description: Provider of AI-based drug discovery and drug repurposing for orphan CNS diseases via the SOM AI PRO platform, validated by two successful Phase 2 trials (TTR amyloidosis; chorea in Huntington’s). Pipeline includes SOM3355 (oral VMAT2 inhibitor, Phase 2b), SOM0226 (TTR stabilizer, outlicensed), SOM1311 (PKU chaperone, expected to enter Phase 2a in 2024), and SOM0034 (DMD program, Phase 2 expected 2025).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SOM Biotech company profile →
Bioquell Logo

Bioquell

HQ: United Kingdom Website
  • Description: Provider of biodecontamination systems and services specializing in Hydrogen Peroxide Vapor technology to eliminate bacteria, viruses, fungi, and spores. Products include Bioquell Hydrogen Peroxide Vapour Decontamination (35% H2O2 vapor for surface and airborne pathogen elimination), Rapid Bio-Decontamination Service, ProteQ automated room decontamination, and Qube isolators for sterility testing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bioquell company profile →
Appili Therapeutics Logo

Appili Therapeutics

HQ: Canada Website
  • Description: Provider of anti-infective pharmaceutical development solutions, addressing unmet medical needs with improvements to established therapies and new classes of anti-infectives. Pipeline includes ATI-1701, a live-attenuated tularemia vaccine candidate; ATI-1801, a topical antiparasitic for cutaneous leishmaniasis; and LIKMEZ (ATI-1501), an oral taste-masked metronidazole suspension.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Appili Therapeutics company profile →
Meretek Diagnostics Logo

Meretek Diagnostics

HQ: United States Website
  • Description: Provider of non-invasive, non-radioactive breath tests and instruments for diagnostic applications, offering BreathTek UBT and BreathTek-UBiT collection kits for qualitative detection of urease associated with Helicobacter pylori in the human stomach, supporting initial diagnosis and post-treatment monitoring of Helicobacter pylori infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Meretek Diagnostics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Amicrobe

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Amicrobe

2.2 - Growth funds investing in similar companies to Amicrobe

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Amicrobe

4.2 - Public trading comparable groups for Amicrobe

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Amicrobe

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Amicrobe

What does Amicrobe do?

Amicrobe is a provider of advanced biomaterials to prevent and treat infections, offering Amicidin-α Surgical gel for clean and clean-contaminated surgical procedures; Amicidin-β Solution for contaminated and infected tissues with tissue cleansing and microbicidal activity; Amicidin-α PFC for military prolonged field settings (up to 72 hours); and Amicidin-β/EF for emergency settings, including trauma and emergency cesarean delivery.

Who are Amicrobe's competitors?

Amicrobe's competitors and similar companies include DDL, SOM Biotech, Bioquell, Appili Therapeutics, and Meretek Diagnostics.

Where is Amicrobe headquartered?

Amicrobe is headquartered in United States.

How many employees does Amicrobe have?

Amicrobe has 1,000 employees 🔒.

When was Amicrobe founded?

Amicrobe was founded in 2010 🔒.

What sector and industry vertical is Amicrobe in?

Amicrobe is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Amicrobe

Who are the top strategic acquirers in Amicrobe's sector and industry

Top strategic M&A buyers and acquirers in Amicrobe's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Amicrobe?

Top strategic M&A buyers groups and sectors for Amicrobe include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Amicrobe's sector and industry vertical

Which are the top PE firms investing in Amicrobe's sector and industry vertical?

Top PE firms investing in Amicrobe's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Amicrobe's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Amicrobe's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Amicrobe's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Amicrobe include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Amicrobe's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Amicrobe?

The key public trading comparables and valuation benchmarks for Amicrobe include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Amicrobe for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Amicrobe with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Amicrobe's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Amicrobe with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Amicrobe's' sector and industry vertical?

Access recent funding rounds and capital raises in Amicrobe's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Amicrobe